Short Term Feeding for Asian Patients With Liver Cirrhosis

This study has been completed.
Sponsor:
Information provided by:
University of Malaya
ClinicalTrials.gov Identifier:
NCT01165073
First received: July 16, 2010
Last updated: February 27, 2011
Last verified: July 2010
  Purpose

The benefits of short-term naso-gastric feeding in patients with advanced cirrhosis remain uncertain. This was a randomised study comparing naso-gastric feeding and oral feeding in Asian patients with cirrhosis who were admitted to hospital for decompensation.


Condition Intervention
CIRRHOSIS
Dietary Supplement: Osmolite and B.C.A.A.
Dietary Supplement: Normal oral intake & supplementation if necessary

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Short Term Feeding for Hospitalised Asian Patients With Liver Cirrhosis - a Randomised Trial of Naso-gastric vs Oral Feeding

Resource links provided by NLM:


Further study details as provided by University of Malaya:

Primary Outcome Measures:
  • Improvement in Child-Pugh score [ Time Frame: Up to 6 weeks ] [ Designated as safety issue: No ]
    Change in the Child-Pugh score, assessing liver damage in cirrhosis


Secondary Outcome Measures:
  • Improvement in nutritional parameters [ Time Frame: up to 6 weeks ] [ Designated as safety issue: No ]
    Improvement in nutritional anthropometry and assessment tool markers after intervention


Enrollment: 52
Study Start Date: March 2008
Study Completion Date: May 2010
Primary Completion Date: May 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Naso-gastric tube feeding Dietary Supplement: Osmolite and B.C.A.A.
Feeding inserted into enteral tubes
Other Name: Enteral supplementation
Active Comparator: Oral feeding Dietary Supplement: Normal oral intake & supplementation if necessary
Enteral nutrition
Other Name: Enteral supplementation

Detailed Description:

Consecutive patients with decompensated cirrhosis who fitted the inclusion criteria, will be randomised to either naso-gastric or oral feeding. Total feeding will be for 2 weeks only. Following intervention specific nutritional and liver-related parameters will be measured during the 2 weeks and up to 6 weeks later. Comparison between both groups will then be made.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients with decompensated cirrhosis of any etiology.

Exclusion Criteria:

  • Advanced hepatic encephalopathy,
  • Variceal bleeding,
  • Hepatocellular carcinoma.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01165073

Locations
Malaysia
University of Malaya Medical Centre
Kuala Lumpur, Federal Territory, Malaysia, 59100
Sponsors and Collaborators
University of Malaya
Investigators
Study Director: Sanjiv Mahadeva, MRCP University of Malaya
Principal Investigator: Mei-Ling S Tai, MRCP University of Malaya
  More Information

Publications:
Responsible Party: Dr Sanjiv Mahadeva/ Dr Sharon Tai Mei Ling, University of Malaya
ClinicalTrials.gov Identifier: NCT01165073     History of Changes
Other Study ID Numbers: NGVOC1
Study First Received: July 16, 2010
Last Updated: February 27, 2011
Health Authority: Malaysia: Ministry of Health

Keywords provided by University of Malaya:
Cirrhosis
Malnutrition
Enteral nutrition

Additional relevant MeSH terms:
Liver Cirrhosis
Digestive System Diseases
Liver Diseases

ClinicalTrials.gov processed this record on October 21, 2014